Posts by UT Health Science Center - San Antonio
Leukemia, lymphoma squarely in sights of new class of drugs
Researchers have discovered a safe and potent next generation of drugs to fight multiple types of leukemia and lymphoma in adults and children. …
Read Full ArticleRapamycin prevents age-related brain vascular deterioration
A new study shows age-related decreases in blood flow to the brain and memory loss can be modified with the drug rapamycin. …
Read Full ArticleDrug treats type 2 diabetes in children
Results of a recently completed clinical trial of a potential drug to treat Type 2 diabetes in children were announced Sunday [April 28] at the Pediatric Academic Societies 2019 meeting in Baltimore, …
Read Full ArticleFirst-in-human trial of senolytic drugs encouraging
UT Health San Antonio researchers, collaborating with the Mayo Clinic and the Wake Forest School of Medicine, are the first to publish results on the treatment of a deadly age-related disease in human patients with drugs called senolytics. …
Read Full ArticleTiny molecule has big effect in brain tumor studies
A new study by UT Health Science Center San Antonio researchers found that a molecule thousands of times smaller than a gene is able to kill medulloblastoma, the most common childhood brain cancer. …
Read Full ArticleStress can impair memory and reduce brain size in middle age
Adults in their 40s and 50s with higher levels of cortisol–a hormone linked to stress–performed worse on memory and other cognitive tasks than peers of the same age with average cortisol levels, …
Read Full ArticleResearch team finds link between BRCA1 and Ewing sarcoma
Scientists with the Greehey Children’s Cancer Research Institute at UT Health San Antonio have discovered a surprising connection between a breast cancer protein, BRCA1, and a pediatric cancer called Ewing sarcoma. …
Read Full Article